The Role of Alveolar Edema in COVID-19

The coronavirus disease 2019 (COVID-19) has spread over the world for more than one year. COVID-19 often develops life-threatening hypoxemia. Endothelial injury caused by the viral infection leads to intravascular coagulation and ventilation-perfusion mismatch. However, besides above pathogenic mech...

Full description

Bibliographic Details
Main Authors: Shu Yuan, Si-Cong Jiang, Zhong-Wei Zhang, Yu-Fan Fu, Jing Hu, Zi-Lin Li
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/10/8/1897
_version_ 1797524337845075968
author Shu Yuan
Si-Cong Jiang
Zhong-Wei Zhang
Yu-Fan Fu
Jing Hu
Zi-Lin Li
author_facet Shu Yuan
Si-Cong Jiang
Zhong-Wei Zhang
Yu-Fan Fu
Jing Hu
Zi-Lin Li
author_sort Shu Yuan
collection DOAJ
description The coronavirus disease 2019 (COVID-19) has spread over the world for more than one year. COVID-19 often develops life-threatening hypoxemia. Endothelial injury caused by the viral infection leads to intravascular coagulation and ventilation-perfusion mismatch. However, besides above pathogenic mechanisms, the role of alveolar edema in the disease progression has not been discussed comprehensively. Since the exudation of pulmonary edema fluid was extremely serious in COVID-19 patients, we bring out a hypothesis that severity of alveolar edema may determine the size of poorly-ventilated area and the blood oxygen content. Treatments to pulmonary edema (conservative fluid management, exogenous surfactant replacements and ethanol–oxygen vapor therapy hypothetically) may be greatly helpful for reducing the occurrences of severe cases. Given that late mechanical ventilation may cause mucus (edema fluid) to be blown deep into the small airways, oxygen therapy should be given at the early stages. The optimal time and blood oxygen saturation (SpO<sub>2</sub>) threshold for oxygen therapy are also discussed.
first_indexed 2024-03-10T08:55:56Z
format Article
id doaj.art-d2e1474093674cd3b97673bf1fe47cf2
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-10T08:55:56Z
publishDate 2021-07-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-d2e1474093674cd3b97673bf1fe47cf22023-11-22T07:08:51ZengMDPI AGCells2073-44092021-07-01108189710.3390/cells10081897The Role of Alveolar Edema in COVID-19Shu Yuan0Si-Cong Jiang1Zhong-Wei Zhang2Yu-Fan Fu3Jing Hu4Zi-Lin Li5College of Resources, Sichuan Agricultural University, Chengdu 611130, ChinaChengdu Kang Hong Pharmaceutical Group Comp. Ltd., Chengdu 610036, ChinaCollege of Resources, Sichuan Agricultural University, Chengdu 611130, ChinaCollege of Resources, Sichuan Agricultural University, Chengdu 611130, ChinaSchool of Medicine, Northwest University, Xi’an 710069, ChinaDepartment of Cardiovascular Surgery, Xijing Hospital, Medical University of the Air Force, Xi’an 710032, ChinaThe coronavirus disease 2019 (COVID-19) has spread over the world for more than one year. COVID-19 often develops life-threatening hypoxemia. Endothelial injury caused by the viral infection leads to intravascular coagulation and ventilation-perfusion mismatch. However, besides above pathogenic mechanisms, the role of alveolar edema in the disease progression has not been discussed comprehensively. Since the exudation of pulmonary edema fluid was extremely serious in COVID-19 patients, we bring out a hypothesis that severity of alveolar edema may determine the size of poorly-ventilated area and the blood oxygen content. Treatments to pulmonary edema (conservative fluid management, exogenous surfactant replacements and ethanol–oxygen vapor therapy hypothetically) may be greatly helpful for reducing the occurrences of severe cases. Given that late mechanical ventilation may cause mucus (edema fluid) to be blown deep into the small airways, oxygen therapy should be given at the early stages. The optimal time and blood oxygen saturation (SpO<sub>2</sub>) threshold for oxygen therapy are also discussed.https://www.mdpi.com/2073-4409/10/8/1897SARS-CoV-2endothelial injuriesventilation-perfusion mismatchintravascular coagulationalveolar edemaoxygen therapy
spellingShingle Shu Yuan
Si-Cong Jiang
Zhong-Wei Zhang
Yu-Fan Fu
Jing Hu
Zi-Lin Li
The Role of Alveolar Edema in COVID-19
Cells
SARS-CoV-2
endothelial injuries
ventilation-perfusion mismatch
intravascular coagulation
alveolar edema
oxygen therapy
title The Role of Alveolar Edema in COVID-19
title_full The Role of Alveolar Edema in COVID-19
title_fullStr The Role of Alveolar Edema in COVID-19
title_full_unstemmed The Role of Alveolar Edema in COVID-19
title_short The Role of Alveolar Edema in COVID-19
title_sort role of alveolar edema in covid 19
topic SARS-CoV-2
endothelial injuries
ventilation-perfusion mismatch
intravascular coagulation
alveolar edema
oxygen therapy
url https://www.mdpi.com/2073-4409/10/8/1897
work_keys_str_mv AT shuyuan theroleofalveolaredemaincovid19
AT sicongjiang theroleofalveolaredemaincovid19
AT zhongweizhang theroleofalveolaredemaincovid19
AT yufanfu theroleofalveolaredemaincovid19
AT jinghu theroleofalveolaredemaincovid19
AT zilinli theroleofalveolaredemaincovid19
AT shuyuan roleofalveolaredemaincovid19
AT sicongjiang roleofalveolaredemaincovid19
AT zhongweizhang roleofalveolaredemaincovid19
AT yufanfu roleofalveolaredemaincovid19
AT jinghu roleofalveolaredemaincovid19
AT zilinli roleofalveolaredemaincovid19